Synapse - Larry Norton

Search Within

Larry Norton

Results (200)

Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer

Meeting Abstract

Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)

Meeting Abstract

Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Expression patterns of receptor activator of nuclear factor-kB (RANK) and Src in a series of primary breast tumors (BT) and bone metastases (BM) in patients (pts) with metastatic breast cancer (MBC)

Meeting Abstract

Gucalp, A.; Comen, E.; Redana, S.; Evangelista, L.; Giri, D. D.; Zhang, X. H.; Patil, S.; Akram, M.; Norton, L.; Hudis, C. A.; more...
Cancer Research (2011)

Fulltext@MSK | Save

Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer

Journal Article

Gucalp, A.; Sparano, J. A.; Caravelli, J.; Santamauro, J.; Patil, S.; Abbruzzi, A.; Pellegrino, C.; Bromberg, J.; Dang, C.; Theodoulou, M.; more...
Clinical Breast Cancer (2011)

Fulltext@MSK | Save

Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer

Journal Article

Mcarthur, H. L.; Mahoney, K. M.; Morris, P. G.; Patil, S.; Jacks, L. M.; Howard, J.; Norton, L.; Hudis, C. A.
Cancer (2011)

Fulltext@MSK | Save

HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab

Journal Article

Modi, S.; Stopeck, A.; Linden, H.; Solit, D.; Chandarlapaty, S.; Rosen, N.; D'Andrea, G.; Dickler, M.; Moynahan, M. E.; Sugarman, S.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer

Journal Article

Gajria, D.; Feigin, K.; Tan, L. K.; Patil, S.; Geneus, S.; Theodoulou, M.; Norton, L.; Hudis, C. A.; Traina, T. A.
Cancer (2011)

Fulltext@MSK | Save

Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib

Journal Article

Morris, P. G.; Chen, C.; Steingart, R.; Fleisher, M.; Lin, N.; Moy, B.; Come, S.; Sugarman, S.; Abbruzzi, A.; Lehman, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer

Journal Article

Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Breast cancer methylomes establish an epigenomic foundation for metastasis

Journal Article

Fang, F.; Turcan, S.; Rimner, A.; Kaufman, A.; Giri, D.; Morris, L. G. T.; Shen, R.; Seshan, V.; Mo, Q.; Heguy, A.; more...
Science Translational Medicine (2011)

Fulltext@MSK | Save